Production (Stage)
Trinity Biotech plc
TRIB
$0.6341
-$0.0374-5.57%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.17M | 5.32M | 3.69M | 6.26M | 7.25M |
| Total Receivables | 14.60M | 17.71M | 13.01M | 16.69M | 19.03M |
| Inventory | 19.37M | 22.96M | 19.93M | 20.88M | 23.55M |
| Prepaid Expenses | 1.98M | -- | 2.04M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 373.00K | -- | -- |
| Total Current Assets | 41.12M | 45.98M | 39.04M | 43.83M | 49.83M |
|
|
|||||
| Total Current Assets | 41.12M | 45.98M | 39.04M | 43.83M | 49.83M |
| Net Property, Plant & Equipment | 4.62M | 3.91M | 1.89M | 1.80M | 6.08M |
| Long-term Investments | 13.84M | -- | 0.00 | -- | -- |
| Goodwill | 13.84M | -- | 0.00 | -- | -- |
| Total Other Intangibles | 16.55M | 41.79M | 1.17M | 16.16M | 37.14M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.70M | 2.68M | 17.34M | 1.80M | 4.84M |
| Total Assets | 103.29M | 94.36M | 59.44M | 63.60M | 97.90M |
|
|
|||||
| Total Accounts Payable | 6.83M | 23.07M | 3.89M | 10.63M | 14.45M |
| Total Accrued Expenses | 14.37M | -- | 8.07M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.50M | 2.36M | 1.90M | 1.81M | 210.00K |
| Total Finance Division Other Current Liabilities | 8.40M | 333.00K | 1.18M | 302.00K | 71.00K |
| Total Other Current Liabilities | 8.40M | 333.00K | 1.18M | 302.00K | 71.00K |
| Total Current Liabilities | 32.10M | 25.77M | 15.04M | 12.74M | 14.73M |
|
|
|||||
| Total Current Liabilities | 32.10M | 25.77M | 15.04M | 12.74M | 14.73M |
| Long-Term Debt | 87.79M | 80.77M | 54.65M | 54.28M | 57.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.48M | 10.20M | 10.87M | 10.92M | 11.82M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.11M | 7.01M | 2.83M | 3.14M | 7.02M |
| Total Liabilities | 138.47M | 123.76M | 83.38M | 81.08M | 91.26M |
|
|
|||||
| Common Stock & APIC | 67.59M | 52.28M | 48.59M | 48.59M | 55.26M |
| Retained Earnings | -79.12M | -57.79M | -48.64M | -42.14M | -17.93M |
| Treasury Stock & Other | -23.65M | -23.89M | -23.90M | -23.94M | -30.70M |
| Total Common Equity | -35.18M | -29.40M | -23.95M | -17.49M | 6.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.18M | -29.40M | -23.95M | -17.49M | 6.63M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.18M | -29.40M | -23.95M | -17.49M | 6.63M |
|
|
|||||